MNX internals
| ||||||||||||||||||||||||||||
| Parent-child relations graph |
|
|||||||||||||||||||||||||||
| Identifier | Description |
|---|---|
CHEBI:140933 chebi:140933 RZCPXIZGLPAGEV-SUHLLOIRSA-N | 5-iPF2alpha-VI 5-iPF2a-VI |
lipidmaps:LMFA03110012 lipidmapsM:LMFA03110012 RZCPXIZGLPAGEV-SUHLLOIRSA-N | (+/-) 5-iPF2alpha-VI-(d11) 5,9S,11R-trihydroxy-6E,14Z-prostadienoic acid-cyclo[8S,12R]-(d11) |
lipidmaps:LMFA03110011 lipidmapsM:LMFA03110011 RZCPXIZGLPAGEV-SUHLLOIRSA-N | (+/-) 5-iPF2alpha-VI 5(R,S)-5-F2t-IsoP 5,9S,11R-trihydroxy-6E,14Z-prostadienoic acid-cyclo[8S,12R] 5-iso-PGF2a VI FA 20:3 Isoprostane F2alpha-I O3 iPF2alpha-I |
CHEBI:228798 chebi:228798 RZCPXIZGLPAGEV-SUHLLOIRSA-N | (+/-)5-iPF2alpha-VI (E)-7-[(1S,2R,3R,5S)-3,5-dihydroxy-2-[(Z)-oct-2-enyl]cyclopentyl]-5-hydroxyhept-6-enoic acid |
metacyc.compound:CPD-24740 metacycM:CPD-24740 RZCPXIZGLPAGEV-SUHLLOIRSA-M | 5-iso prostaglandin F2alpha-VI (8beta)-5,9alpha,11alpha-trihydroxy-prosta-6E,14Z-dien-1-oate 5-iPF2a-VI 5-iPF2alpha-VI 5-iso PGF2alpha-VI iPF2alpha-I isoprostane F2alpha-I |